Novartis | NOVN - Debitur Perdagangan

Harga Saham
116.18
Perubahan Harian
0.58 0.50%
Bulanan
-10.35%
Tahunan
18.41%
Q1 Perkiraan
112.76




Debitur Perdagangan Perubahan Tanggal
AbbVie USD 12.77B 132M 2025-09
Alcon AG USD 2.54B 596M 2025-12
Almirall EUR 175.93M 17.87M 2025-12
Amgen USD 9.57B 1.08B 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
Autolus Therapeutics Ltd USD 91.36M 58.83M 2025-09
Bayer EUR 14.19B 720M 2025-12
Biogen USD 1.85B 234M 2025-09
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Eli Lilly USD 19.46B 2.25B 2025-09
Fresenius EUR 4.08B 18M 2025-09
Fresenius Medical Care EUR 3.66B 382.33M 2025-12
Galapagos EUR 199.75M 122.08M 2025-12
Genmab DKK 1.17B 119M 2025-12
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
GRIFOLS EUR 852M 244.52M 2025-12
Hikma Pharmaceutical USD 1.08B 27M 2025-12
J&J USD 17.61B 235M 2025-09
Lonza CHF 1.78B 55M 2025-12
Merck EUR 4.44B 293M 2025-12
Merck USD 12.12B 596M 2025-09
Novartis USD 12.29B 3.3B 2025-12
Novartis USD 12.29B 3.3B 2025-12
Novo Nordisk DKK 95.05B 2.4B 2025-12
Orion EUR 429.2M 46.9M 2025-09
Pfizer USD 18.12B 2.02B 2025-09
Philips EUR 3.8B 266M 2025-12
Recordati EUR 699.76M 472K 2025-09
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 397M 100M 2025-12
UCB EUR 1.97B 54M 2025-12